Jonas Hansson

Junior Venture Partner and serves as CEO of certain companies in which the HealthCap funds have invested. Prior to joining HealthCap in 2008 Jonas held various sales and marketing positions within Janssen Pharmaceutica (J&J). Jonas received his M.Sc. in Pharmacy from Uppsala University and his master thesis was presented at The Scripps Research Institute in La Jolla, California. Jonas also holds an MBA from Stockholm School of Economics. Jonas Hansson is currently the CEO of Wilson Therapeutics AB.